Birlasoft helps medtech unify R&D data

Medical-device R&D runs on data, but most big companies still treat that data like separate islands. Clinical trial systems sit in one place. Lab results sit in another. Device telemetry lands somewhere else. Regulatory teams build their own reporting stacks on top. Birlasoft’s new case study is basically about what happens when a large medtech company decides that this setup has become the bottleneck — and rebuilds the foundation first. The client was a Fortune 10 global medical device manufacturer, and the fix was an AI-powered, cloud-native data lake built to unify R&D information across the stack. (birlasoft.com) ### What was broken? The company had grown across products, geographies, and likely acquisitions, and the result was familiar: too much important data trapped in systems that were never meant to talk to each other. Birlasoft says researchers lacked a unified view, regulatory (birlasoft.com). That is the real story here — not “AI” in the abstract, but the old plumbing underneath it. (birlasoft.com) ### What did Birlasoft actually build? The centerpiece was a centralized data platform — a cloud-native, AI-powered data lake. It ingested both structured and unstructured information from across the enterprise and harmonized it into a single source of truth for R&D. The name(birlasoft.com)t a reporting warehouse. It was meant to connect product development, evidence generation, and compliance work in one environment. (birlasoft.com) ### Why does that matter for medtech? Because medical-device companies do not just need faster insight. They need traceable insight. A flashy model is useless if nobody can show where the data came from, whether standards were applied consistently, or whether patient and devi(birlasoft.com)ty problem, with HIPAA, GDPR, and FDA requirements all in the background. In medtech, “better data access” and “better compliance posture” are often the same project wearing different clothes. (birlasoft.com) ### Why start with the data lake? Because AI in R&D usually breaks before the model does. It breaks when source systems disagree, when metadata is missing, when terms are inconsistent, or when teams cannot trust outputs enough to use them in regulated workflows. A unified lak(birlasoft.com)s like building a smarter dashboard and more like replacing a patchwork of extension cords with an actual electrical panel. (birlasoft.com) ### Is this a one-off pitch piece? It is a vendor case study, so yes — it is marketing. But it also lines up with Birlasoft’s broader medtech push. The company has been packaging life-sciences and medtech work around AI, compliance, connected devices, and digital transformati(birlasoft.com)ot an old recycled asset. (birlasoft.com) ### What should biotech and SaaS teams take from it? The useful lesson is pretty simple: if you want AI to help in regulated R&D, make the data auditable before you make it intelligent. Unify the sources. Define governance early. Build for both analytics and traceability. The companies that do this well will not just (birlasoft.com)and a much better shot at using AI in places that actually matter. (birlasoft.com) ### Bottom line? Birlasoft did not unveil a miracle model. It showed the less glamorous but more important move — one big medtech company cleaning up the R&D data layer so AI can become usable, governable, and worth trusting. (birlasoft.com)